Matthew Ho

12PUBLICATIONS
45CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Respiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 09, 2026
Monoclonal Gammopathy of Thrombotic Significance.

|May 15, 2026
Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

|Jan 15, 2026
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

Matthew Ho, Luca Paruzzo, Julia Han Noll

|Aug 07, 2023
Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities.

Matthew Ho, Saurabh Zanwar, Jonas Paludo

|Oct 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.

Matthew Ho, Saurabh Zanwar, Francis K Buadi

|Jun 14, 2022
Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.

Matthew Ho, Maria Moscvin, Soon Khai Low

Pageof 2

Frequent Collaborators

4 joint publications

Saurabh Zanwar

3 joint publications

Marco Ruella

3 joint publications

Federico Stella

3 joint publications

S Vincent Rajkumar